kiorapharma.com (KPRX) Year-over-year earnings per share growth for the last twelve months

Graphic logo of Kiora Pharmaceuticals Inc. (KPRX)

The stable operation of Kiora Pharmaceuticals (KPRX) laboratory lines ensures the development of ophthalmology products. The quarterly EPS change reflects current profit dynamics, where the parameter value equals -4570.50. The biotech's prospects depend on successes in retinal therapy and commercialization. However, investors should consider risks of capital dilution, patent disputes, and a narrow market segment.

kiorapharma.com (KPRX) Quarterly EPS earnings growth: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Kiora Pharmaceuticals

- share price and expert price forecast:
Summary company analytics:Kiora Pharma - KPRX
Manufactured product of kiorapharma.com

The stability of Kiora Pharmaceuticals (KPRX) supply chains for ophthalmology components correlates directly with the percentage change in quarterly EPS. This indicator measures the growth rate of net income per share, allowing investors to assess the efficiency of business capitalization; however, purchasing the asset at the peak of the chart may result in overpaying for the stock.

Competitor analysis

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth HROW (Harrow Inc)|Year-over-year net earnings per share change for the last twelve months Viridian Corp (VRDN)|LENZ - Year-over-year earnings per share growth for the last twelve months|Oculis - Year-over-year earnings per share growth rate for the last twelve months|EyePoint Pharmaceuticals (EYPT) - Year-over-year earnings per share growth for the last twelve months|Kodiak Sciences Inc (KOD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ALDX|KALA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IRD|OKYO: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adverum Biotechnologies ADVM|Quarterly EPS earnings growth Outlook Pharma OTLK|Clearside Biomedical - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months NBY|Alimera Sciences (ALIM) - Year-over-year earnings per share growth for the last twelve months|Eyenovia Inc. - Year-over-year earnings per one share growth for the last 12 months|GHSI (Guardion Health Sciences) - Quarterly EPS earnings growth|Ocuphire Pharma - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)